Thane Kreiner founded, led, and developed multiple life sciences startups before joining Santa Clara University as Executive Director of the department that houses its prestigious GSBI program for social entrepreneurs.
A neuroscientist by training, Stanford Business School graduate, and an experienced serial entrepreneur himself, Thane brings a pragmatic optimism to his role at the helm of the Center for Science, Technology, and Society at SCU. Listen below to is interview to learn more about GSBI, what kinds of social entrepreneurs should apply, past successes, and his advice for those thinking about launching a social innovation venture.
What is GSBI?
Piloted in 2003, Santa Clara University’s Global Social Benefit Institute (GSBI) applies Silicon Valley acumen to help scale proven early-stage impact innovation for-profit and nonprofit ventures. It does this through offering 2 curriculum programs: the GSBI Accelerator is a nine-month program that combines online modules with mentor meetings and culminates in a in-residence bootcamp at SCU’s campus in California’s Silicon Valley. Social entrepreneurs can also engage through the GSBI Online program—which provides more general startup training through an exclusively online medium.
Both GSBI programs focus on startups that have progressed past early ideation (i.e. blueprint) and validation stages of their startup and are in the ‘prepare to scale’ stage of startup development, as articulated in From Blueprint to Scale.
Alumni of the program include Kiva, WE CARE Solar, Husk Power Systems, World of Good and over 200 other social innovation ventures with entrepreneurs spanning over 50 countries.
Applications for GSBI are open now and due this Thursday, October 31st 2013.
Meet Thane Kreiner
I had a chance to catch up with Thane about GSBI and his own experience and views on the importance of resources for social entrepreneurship. He is articulate and passionate about social innovation, and incredibly well-versed on the Silicon Valley startup experience.
Thane’s education spans a B.S. in Chemistry from University of Texas, Austin to a PhD in Neurosciences from Stanford School of Medicine, to an MBA from Stanford GSB. His professional portfolio includes a number startups that he has founded, led, and guided through development, such as:
Second Genome, Presage Biosciences, iZumi Bio, Inc. (now iPierian).